The @US_FDA approved #Riabni @Amgen the third #biosimilar to Rituxan. https://t.co/l13aUad4EK #biosimilars #Rituxan #rituximab #fda
The @US_FDA approved #Riabni @Amgen the third #biosimilar to Rituxan. https://t.co/l13aUad4EK #biosimilars #Rituxan #rituximab #fda